Literature DB >> 36040252

High-efficiency recombinant protein purification using mCherry and YFP nanobody affinity matrices.

Anh T Q Cong1, Taylor L Witter1, Matthew J Schellenberg1.   

Abstract

Mammalian cell lines are important expression systems for large proteins and protein complexes, particularly when the acquisition of post-translational modifications in the protein's native environment is desired. However, low or variable transfection efficiencies are challenges that must be overcome to use such an expression system. Expression of recombinant proteins as a fluorescent protein fusion enables real-time monitoring of protein expression, and also provides an affinity handle for one-step protein purification using a suitable affinity reagent. Here, we describe a panel of anti-GFP and anti-mCherry nanobody affinity matrices and their efficacy for purification of GFP/YFP or mCherry fusion proteins. We define the molecular basis by which they bind their target proteins using X-ray crystallography. From these analyses, we define an optimal pair of nanobodies for purification of recombinant protein tagged with GFP/YFP or mCherry, and demonstrate these nanobody-sepharose supports are stable to many rounds of cleaning and extended incubation in denaturing conditions. Finally, we demonstrate the utility of the mCherry-tag system by using it to purify recombinant human topoisomerase 2α expressed in HEK293F cells. The mCherry-tag and GFP/YFP-tag expression systems can be utilized for recombinant protein expression individually or in tandem for mammalian protein expression systems where real-time monitoring of protein expression levels and a high-efficiency purification step is needed.
© 2022 The Protein Society.

Entities:  

Keywords:  protein purification; protein structure; protein-protein interaction; recombinant protein expression; single-domain antibody (sdAb nanobody)

Mesh:

Substances:

Year:  2022        PMID: 36040252      PMCID: PMC9413470          DOI: 10.1002/pro.4383

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.993


  28 in total

1.  A versatile nanotrap for biochemical and functional studies with fluorescent fusion proteins.

Authors:  Ulrich Rothbauer; Kourosh Zolghadr; Serge Muyldermans; Aloys Schepers; M Cristina Cardoso; Heinrich Leonhardt
Journal:  Mol Cell Proteomics       Date:  2007-10-21       Impact factor: 5.911

2.  Purification of GFP fusion proteins with high purity and yield by monoclonal antibody-coupled affinity column chromatography.

Authors:  Ran Zhuang; Yuan Zhang; Rui Zhang; Chaojun Song; Kun Yang; Angang Yang; Boquan Jin
Journal:  Protein Expr Purif       Date:  2008-02-08       Impact factor: 1.650

3.  A rapid method for titrating baculovirus stocks using the Sf-9 Easy Titer cell line.

Authors:  Ralph Hopkins; Dominic Esposito
Journal:  Biotechniques       Date:  2009-09       Impact factor: 1.993

4.  Processing of X-ray diffraction data collected in oscillation mode.

Authors:  Z Otwinowski; W Minor
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

5.  ZATT (ZNF451)-mediated resolution of topoisomerase 2 DNA-protein cross-links.

Authors:  Matthew J Schellenberg; Jenna Ariel Lieberman; Andrés Herrero-Ruiz; Logan R Butler; Jason G Williams; Ana M Muñoz-Cabello; Geoffrey A Mueller; Robert E London; Felipe Cortés-Ledesma; R Scott Williams
Journal:  Science       Date:  2017-09-14       Impact factor: 47.728

6.  Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins.

Authors:  Tim Waterboer; Peter Sehr; Kristina M Michael; Silvia Franceschi; John D Nieland; Thomas O Joos; Markus F Templin; Michael Pawlita
Journal:  Clin Chem       Date:  2005-08-11       Impact factor: 8.327

7.  Insights into the conformational equilibria of maltose-binding protein by analysis of high affinity mutants.

Authors:  Patrick G Telmer; Brian H Shilton
Journal:  J Biol Chem       Date:  2003-06-06       Impact factor: 5.157

8.  A robust pipeline for rapid production of versatile nanobody repertoires.

Authors:  Peter C Fridy; Yinyin Li; Sarah Keegan; Mary K Thompson; Ilona Nudelman; Johannes F Scheid; Marlene Oeffinger; Michel C Nussenzweig; David Fenyö; Brian T Chait; Michael P Rout
Journal:  Nat Methods       Date:  2014-11-02       Impact factor: 28.547

Review 9.  The Therapeutic Potential of Nanobodies.

Authors:  Ivana Jovčevska; Serge Muyldermans
Journal:  BioDrugs       Date:  2020-02       Impact factor: 5.807

10.  BRCA1-BARD1 regulates transcription through modulating topoisomerase IIβ.

Authors:  Heeyoun Bunch; Jaehyeon Jeong; Keunsoo Kang; Doo Sin Jo; Anh T Q Cong; Deukyeong Kim; Donguk Kim; Dong-Hyung Cho; You Mie Lee; Benjamin P C Chen; Matthew J Schellenberg; Stuart K Calderwood
Journal:  Open Biol       Date:  2021-10-06       Impact factor: 6.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.